Evaluate INBX stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in INBX? | Glauxie AI

Q: What are the risks of investing in INBX?

Inhibrx Biosciences, Inc. (INBX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Mark Paul Lappe. Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates... Employees: 1,000,000.

Q: How much debt does INBX have?

Review INBX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is INBX a good long-term investment?

Evaluate INBX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in INBX?

🦉

Inhibrx Biosciences, Inc. (INBX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMark Paul Lappe

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2...

Key Executives

Name	Title
Ashraf Amanullah	Executive Vice President & Chief Technical Operations Officer
Bonne Adams	Vice President of Operations
Carlos Bais	EVice President & Chief Scientific Officer
David Matly	President
Josep Garcia	Executive Vice President & Chief Clinical Development Officer
Kate Burke	Vice President of Accounting

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

INBX Profile Financials

Is INBX stock safe? How much debt does INBX have? Is INBX a good long-term investment?